The new ARIA guidelines: Putting science into practice

Clinical and Experimental Allergy Reviews

Volumn 2, Issue 1, 2002, Pages 38-43

  Bousquet, J ^a  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

Allergy; Antihistamines; ARIA guidelines; Asthma; Conjunctivitis; Cromones; Topical corticosteroids

Indexed keywords

ANTIGEN; ANTIINFLAMMATORY AGENT; CHROMONE DERIVATIVE; CORTICOSTEROID; CYTOKINE; DECONGESTIVE AGENT; HISTAMINE H1 RECEPTOR ANTAGONIST;

ALLERGIC ASTHMA; ALLERGIC CONJUNCTIVITIS; ALLERGIC RHINITIS; ANAPHYLAXIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG EFFICACY; DRUG FATALITY; HUMAN; IMMUNOTHERAPY; MENTAL FUNCTION; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SOCIAL BEHAVIOR; TH2 CELL; TREATMENT OUTCOME;

EID: 0036425170     PISSN: 14729725     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1472-9725.2002.00033.x     Document Type: Article

References (24)

1. Howarth PH, Holmberg K. Allergic rhinitis: An increasing clinical problem. Allergy 1995; 50 (Suppl.):4-5.
2. Strachan D, Sibbald B, Weiland S et al. Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: The International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol 1997; 8:161-76.
3. Ulrik CS, von Linstow ML, Backer V. Prevalence and predictors of rhinitis in Danish children and adolescents. Allergy 2000; 55:1019-24.
4. Linneberg A, Nielson NH, Madsen F et al. Increasing prevalence of specific IgE to aeroallergens in an adult population: Two crosssectional surveys 8 years apart: The Copenhagen Allergy Study. J Allergy Clin Immunol 2000; 106:247-52.
5. Bousquet J, Bullinger M, Fayol C et al. Assessment of quality of life in patients with perennial allergic rhinitis with the French Version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol 1994; 94:182-8.
6. Stewart AL, Hays RD, Ware JE Jr. The MOS Short-Form General Health Survey. Reliability and validity in a patient population. Med Care 1988; 26:724-35.
7. Stewart AL, Ware JE, eds. Measuring Functioning and Well-Being. The Medical Outcomes Study Approach. Durham, North Carolina: Duke University Press, 1992.
8. Leynaert B, Neukirch C, Lirad R et al. Quality of life in allergic rhinitis and asthma. A population-based study of young adults. Am J Respir Crit Care Med 2000; 162:1391-6.
9. Cerveri I, Locatelli F, Zoia MC et al. International variations in asthma treatment compliance: The results of the European Community Respiratory Health Survey (ECRHS). Eur Respir J 1999; 14:288-94.
10. International Rhinitis Management Working Group. Definition and classification of rhinitis. Allergy 1994; 49 (Suppl. 19):5-34.
11. van Cauwenberge P, Bachert C, Passalacqua G et al. Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy 2000; 55:116-34.
12. Bousquet J, van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma (ARIA Workshop Report). J Allergy Clin Immunol 2001; 108 (5, Part 2, Suppl.):S147-334.
13. Wahn U, Lau S, Bergmann R et al. Indoor allergen exposure is a risk factor for sensitization during the first three years of life. J Allergy Clin Immunol 1997; 99:763-9.
14. Sears MR, Herbison GP, Holdaway MD et al. The relative risk of sensitivity to grass pollen, house dust mite and cat dander in the development of childhood asthma. Clin Exp Allergy 1989; 19:419-24.
15. Boner AL, Niero E, Antolini I et al. Pulmonary function and bronchial hyperreactivity in asthmatic children with house dust mite allergy during prolonged stay in Italian Alps. Ann Allergy 1985; 55:42-5.
16. Bousquet J, Lockey R, Malling H-J. Allergen immunotherapy: Therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 1998; 102:558-62.
17. Durham SR, Walker SM, Varga E-M et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl Med J 1999; 341:468-75.
18. Durham SR, Till SJ. Immunologic changes associated with allergen immunotherapy. J Allergy Clin Immunol 1998; 102:157-64.
19. Malling H-J. The position of immunotherapy in the European Academy of Allergology and Clinical Immunology. J Invest Allergol Clin Immunol 1997; 7:356-7.
20. Shekelle PG, Woolf SH, Eccles M et al. Developing guidelines. BMJ 1999; 318:593-6.
21. Kay AB. Allergy and allergic diseases. First of two parts. N Engl J Med 2001; 344:30-7.
22. Holgate ST, Davies DE, Lackie PM et al. Epithelial-mesenchymal interactions in the pathogenesis of asthma. J Allergy Clin Immunol 2000; 105:193-204.
23. Leynaert B, Bousquet J, Neukirch C et al. Perennial rhinitis: An independent risk factor for asthma in nonatopic subjects: Results from the European Community Respiratory Health Survey. J Allergy Clin Immunol 1999; 104:301-4
24. Yawn BP, Yunginger JW, Wollan PC et al. Allergic rhinitis in Rochester, Minnesota residents with asthma: Frequency and impact on health care charges. J Allergy Clin Immunol 1999; 103:54-9.